Prednisolone - Inflammatory bowel disease
You are here : Home > Formulary Search > Prednisolone - Inflammatory bowel disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Tablets can be dispersed for immediate administration.
Status 2
Green
Formulations :
- Soluble tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Paediatrics only at SASH.
Paediatrics and oncology at ASPH
Status 3
Green
Formulations :
- Oral solution
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Paediatric doses and NG/NJ tube only
Status 4
Non Formulary
Formulations :
- Gastro-resistant tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Enteric coated tablets - non-formulary
Status 5
Non Formulary
Formulations :
- Foam enema
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Budesonide rectal foam is preferred.
Steroid safety considerations
Documentation
Guidelines (Local)
Policy Statement
Safety Information
Safety Information
PAD Profile
ChemicalSubstance :
Prednisolone
Indication :
Inflammatory bowel disease
Group Name :
Keywords :
IBD, chronic bowel disorders, UC, Ulcerative colitis, Crohn's disease
Brand Names Include :
Predfoam
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Traffic Light Entries :
5
Other Indications
Below are listed other indications that Prednisolone is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Inflammatory bowel disease.
Committee Recommendations (1)
The PCN does not recommend Prednisolone foam enemas as a treatment option for patients with active Ulcerative Colitis
Prednisolone foam enemas will be considered BLACK, for new patients, on the traffic light system
People who are currently receiving prednisolone foam enema should have the option to continue therapy from their usual prescriber until they and their clinicians consider it appropriate to stop.
Primary care prescribers should consider switching patients to budesonide rectal foam and for all new patients.
Prednisolone foam enemas will be considered BLACK, for new patients, on the traffic light system
People who are currently receiving prednisolone foam enema should have the option to continue therapy from their usual prescriber until they and their clinicians consider it appropriate to stop.
Primary care prescribers should consider switching patients to budesonide rectal foam and for all new patients.